Models of Global Collaboration: Practical Approaches to Vaccine Access

The evolving landscape of global health funding and shifting priorities are redefining how we work together. Countries are reshaping how they address the direct impact on critical health infrastructure by strengthening new and existing collaborations between governments and the private sector. Vaccine delivery is one area where these partnerships are already achieving positive results.

Join us for a focused discussion on how nations are advancing local vaccine manufacturing to accelerate health equity. Our panel of experts will offer insights into what national ownership looks like for vaccine development and distribution today, especially as traditional donor support declines. Whether you are a current or future health professional, policymaker, advocate, or researcher, you will gain valuable perspectives on how countries are shaping the future of vaccines and health systems amid shifting global support.

This event is free and open to the public.

Register

Speakers

Juliet Nabyonga-Orem, MBChB, MSc, PhD
Health Systems Advisor, Participatory Governance & Policy, WHO Namibia

Professor Juliet Nabyonga-Orem is a health economist and health systems expert with experience spanning over two decades. She currently serves as Health Systems Advisor in Participatory Governance & Policy at the World Health Organization and has been instrumental in transforming health systems across numerous African countries. Professor Nabyonga-Orem has published extensively in the areas of health systems and services, health financing, health economics, policy analysis and knowledge translation. She serves as editor for several prestigious public health journals and was previously the Editor in Chief of the journal, Health Services Insights.

She is a member of several scientific committees including the Africa Health Economics and Policy Association (AfHEA); Health systems Global (HSG); the Scientific committee of the European and Developing Countries Clinical Trials Partnership (EDCTP) Joint Undertaking. She was also formerly a member of the Portfolio Board for Global Development of the Research council of Norway. Professor Nayonga-Orem is currently a Professor at North-West University (NWU) Potchefstroom Campus, South Africa.

William K. Ampofo, PhD
Executive Director, African Vaccine Manufacturing Initiative

Professor William K. Ampofo is Executive Director of the African Vaccine Manufacturing Initiative and has been a leading advocate for local vaccine manufacturing in Africa for over a decade. Professor Ampofo is the former Chief Executive Officer of the National Vaccine Institute and has led extensive vaccine research, development, and manufacturing in Ghana. An accomplished virologist, he is also an Associate Professor at the University of Ghana’s College of Health Sciences, Noguchi Memorial Institute for Medical Research, and the Department of Medical Laboratory Sciences, where he teaches graduate courses and conducts research on viral diseases. Professor Ampofo serves on numerous national, regional, and global committees dedicated to vaccines, viral diseases, and health security, and has served on several WHO advisory groups focused on influenza vaccines, immunization, pandemic preparedness, and Ebola emergency response.

About the Global Health Coffee Sessions

The Global Health Coffee Sessions virtual series pivots with a new lineup of timely conversations at the intersection of health, policy, and global cooperation. Held on the last Friday of each month from 9:00–10:00 AM ET, this series brings together global health experts, policymakers, and practitioners from Harvard and beyond for dynamic, forward-looking discussions.

All sessions are hosted virtually via Zoom, recorded, and available afterward on our YouTube Channel.

The Harvard Global Health Institute provides a platform for different perspectives and debates within the field of global health through a variety of media. The views expressed in these events and programs are solely those of the speakers, authors, researchers, and participating audience. As such, they do not speak for the institute or the university.